KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Clover Health Investments (CLOV) Long-Term Debt Repayments (2020 - 2021)

Clover Health Investments' Long-Term Debt Repayments history spans 2 years, with the latest figure at $25.9 million for Q2 2021.

For Q2 2021, Long-Term Debt Repayments rose 460.47% year-over-year to $25.9 million; the TTM value through Mar 2022 reached $25.9 million, up 34.39%, while the annual FY2021 figure was $30.9 million, 64.92% up from the prior year.
Long-Term Debt Repayments reached $25.9 million in Q2 2021 per CLOV's latest filing, up from $5.0 million in the prior quarter.
In the past five years, Long-Term Debt Repayments ranged from a high of $25.9 million in Q2 2021 to a low of $4.5 million in Q1 2020.